Other OTC Pharmaceuticals - Central & Western Europe

  • Central & Western Europe
  • In Central & Western Europe, the revenue generated in the market Other OTC Pharmaceuticals amounts to US$9.04bn in 2024.
  • It is projected to experience an annual growth rate of 1.10% (CAGR 2024-2029).
  • Among all countries worldwide, the in the United States leads with the highest revenue of US$7,171.00m in 2024.
  • In terms of per capita figures, each person in Central & Western Europe generates revenues of US$26.95 in 2024.
  • In Central & Western Europe, Germany leads the Other OTC Pharmaceuticals market with a wide range of high-quality products.

Key regions: Europe, Germany, United States, Brazil, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Central & Western Europe is experiencing steady growth due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences:
Customers in Central & Western Europe are increasingly seeking self-care options and are becoming more proactive in managing their health. This shift in consumer behavior is driving the demand for over-the-counter (OTC) pharmaceuticals, as they offer convenience, accessibility, and affordability. Additionally, customers are increasingly looking for natural and herbal remedies, as well as products that address specific health concerns such as allergies, digestive issues, and sleep disorders.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals market in Central & Western Europe is the growing popularity of online and e-commerce platforms for purchasing healthcare products. This trend is driven by the convenience and wide product selection offered by online retailers. Customers can easily compare prices, read reviews, and have the products delivered to their doorstep, making it a preferred option for many.Another trend in the market is the increasing focus on preventive healthcare. As customers become more health-conscious, they are seeking products that can help them maintain their well-being and prevent common ailments. This has led to a rise in demand for vitamins, supplements, and preventive treatments.

Local special circumstances:
Central & Western Europe is home to a diverse population with varying healthcare needs. Each country in the region has its own regulations and healthcare system, which can impact the availability and accessibility of OTC pharmaceuticals. For example, some countries may have stricter regulations on the sale of certain products, while others may have a more liberal approach. Additionally, cultural factors and traditional remedies may influence customer preferences in specific countries.

Underlying macroeconomic factors:
The growing Other OTC Pharmaceuticals market in Central & Western Europe is also influenced by macroeconomic factors such as population growth, increasing disposable income, and aging populations. As the population continues to grow and age, the demand for healthcare products is expected to rise. Moreover, rising disposable income allows customers to spend more on healthcare and wellness products.In conclusion, the Other OTC Pharmaceuticals market in Central & Western Europe is witnessing growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. Customers are increasingly seeking self-care options, driving the demand for OTC pharmaceuticals. Online platforms are becoming popular for purchasing healthcare products, and there is a growing focus on preventive healthcare. The diverse population and varying regulations in the region also impact the market. Finally, population growth, increasing disposable income, and aging populations contribute to the market's development.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)